First and only study on harmful effects of infants prenatally exposed to ecstasy

February 28, 2012

A study led by Case Western Reserve University School of Medicine, in collaboration with the University of East London UK, and Swansea University UK, is the first to show the effects of the drug ecstasy on fetal and infant development.

Ecstasy is a stimulant and hallucinogen, and is one of the most widely used illegal drugs among young people, with a range of damaging effects. It is known scientifically as 3,4-methylenedioxymethamphetamine or MDMA. This international prospective study, published in the Feb. 28 issue of , shows that use of among pregnant women affects the chemical signaling that determines a baby's gender, and, contributes to developmental delays among infants.

"The potential harmful effects of ecstasy exposure on prenatal and infant development have long been a concern," said Lynn T. Singer, PhD, the study's principal investigator, professor of environmental health sciences, pediatrics and psychiatry at Case Western Reserve University School of Medicine, and, deputy provost and vice president for academic affairs at the university. "The drug's negative effects are particularly risky for pregnant women, who may use the drug without being aware of their condition," she adds.

The study's 96 participants were recruited from The University of East London (UEL) Drugs and Infancy Study (DAISY), which focused on recreational drug use among pregnant women. Prior to and during pregnancy, the women were interviewed about their substance abuse, including their use of ecstasy. They were also evaluated for and related difficulties that stemmed from their drug use.

Researchers compared infants exposed to ecstasy to non-exposed infants, at birth and at fourth months of age. They examined the babies' growth and noted any potential delays in and attainment of milestones in coordinated movements and gross motor development.

Most of the women surveyed had taken a variety of prior to, and, during pregnancy. Differences among the women were analyzed to control for confounding variables. Researchers found that women who reported using ecstasy while pregnant suffered more negative social consequences as a result of their ecstasy use, than non-users. These included more job, health and social problems.

The use of ecstasy during pregnancy also appeared to affect the ratio of male to female babies born. Researchers noted a preponderance of male births among women who used ecstasy while pregnant, whereas typically the sex ratio at birth is half and half.

"The research findings also suggests there are some neurochemical effects of the drug that seem to affect the motor functioning of infants," says Derek Moore, PhD, professor of psychology at The University of East London, director of the school's Institute for Research in Child Development (IRCD), and co-principal investigator on this research. He coordinated the research in the UK.

At four months, ecstasy-exposed infants in the study demonstrated poorer quality of coordinated movement and lower milestone attainment, according to Dr. Moore. For example, some ecstasy-exposed infants balanced their heads at a later age than babies that were not exposed to the drug. Others showed delays in eye hand coordination, turning from back to side and being able to sit with support, which could heighten the potential for additional later on.

The research underscores a potential link between the amounts of ecstasy exposure to poorer motor quality, which warrants further study, Dr. Singer says.

Ecstasy is such a widely used drug throughout the world, that if prenatal exposure is shown to be harmful, many infants could be affected, the researchers say.

"The psychomotor and related psychological problems identified in these four-month old babies are very worrying, but perhaps not particularly surprising," says Andy Parrott, BSc, PhD, professor of psychology at Swansea University in Wales, and, the other co-principal investigator on this research. "Ecstasy can deplete the level of serotonin, which is important neurotransmitter for many brain functions, including gross motor control."

Serotonin carries nerve impulses between cells, which regulate mood states, sleep and anxiety. Early in fetal development, serotonin plays a vital role in brain formation. If the level and behavior of serotonin is altered, it can have long-term effects on learning and memory, basic research models have shown.

The new research grew out of Dr. Singer's ongoing research into high-risk infants and the effects that drugs have on fetal and infant development. She became familiar with the work of Dr. Parrott at Swansea and Dr. Moore and John Turner, PhD, principal lecturer in the School of Psychology at the University of East London, and initiated this important prospective study to investigate the prospective effects of ecstasy on subsequent child development.

The study was funded by the National Institute on Drug Abuse, part of the National Institutes of Health. It is funded to collect data up to 18 months after an infant's birth. Researchers are examining the same women and children 12 months after birth to assess if the slight delays noted early on worsen or persist, potentially signaling the long-term negative effect of prenatal ecstasy exposure.

The researchers hope to obtain additional funding to continue the study well into the infants' childhood years. The fear that, in the future, the infants exposed to ecstasy while prior to birth may experience long-term deficits that will negatively affect their memory, learning capacity, and emotional development.

Explore further: Long-term users of ecstasy risk structural brain damage

Related Stories

Long-term users of ecstasy risk structural brain damage

April 7, 2011
Long term users of the popular recreational drug ecstasy (MDMA) risk structural brain damage, suggests preliminary research published online in the Journal of Neurology, Neurosurgery and Psychiatry.

Ecstasy drug produces lasting toxicity in the brain

December 5, 2011
Recreational use of Ecstasy – the illegal "rave" drug that produces feelings of euphoria and emotional warmth – is associated with chronic changes in the human brain, Vanderbilt University investigators have discovered.

Ecstasy associated with chronic change in brain function

May 3, 2011
the illegal "rave" drug that produces feelings of euphoria and emotional warmth – has been in the news recently as a potential therapeutic. Clinical trials are testing Ecstasy in the treatment of post-traumatic stress ...

Recommended for you

Concern with potential rise in super-potent cannabis concentrates

July 21, 2017
University of Queensland researchers are concerned the recent legalisation of medicinal cannabis in Australia may give rise to super-potent cannabis concentrates with associated harmful effects.

Findings link aldosterone with alcohol use disorder

July 18, 2017
A new study led by scientists at the National Institute on Alcohol Abuse and Alcoholism (NIAAA), part of the National Institutes of Health, demonstrates that aldosterone, a hormone produced in the adrenal glands, may contribute ...

Depression among young teens linked to cannabis use at 18

July 17, 2017
A study looking at the cumulative effects of depression in youth, found that young people with chronic or severe forms of depression were at elevated risk for developing a problem with cannabis in later adolescence.

Why does prenatal alcohol exposure increase the likelihood of addiction?

July 7, 2017
One of the many negative consequences when fetuses are exposed to alcohol in the womb is an increased risk for drug addiction later in life. Neuroscientists in the University at Buffalo Research Institute on Addictions are ...

Researchers say U.S. policies on drugs and addiction could use a dose of neuroscience

June 23, 2017
Tens of thousands of Americans die from drug overdoses every year – around 50,000 in 2015 – and the number has been steadily climbing for at least the last decade and a half, according to the National Institute on Drug ...

Study provides further support for genetic factors underlying addictions

June 13, 2017
Impairment of a particular gene raises increases susceptibility to opioid addiction liability as well as vulnerability to binge eating according to a new study.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.